ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P03951


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name FA11_HUMAN
Primary accession number P03951
Secondary accession numbers Q4W5C2 Q9Y495
Integrated into Swiss-Prot on October 23, 1986
Sequence was last modified on October 23, 1986 (Sequence version 1)
Annotations were last modified on    June 16, 2009 (Entry version 130)
Name and origin of the protein
Protein name Coagulation factor XI [Precursor]
Synonyms FXI
EC 3.4.21.27
Plasma thromboplastin antecedent
PTA
Contains Coagulation factor XIa heavy chain
Coagulation factor XIa light chain
Gene name
Name: F11
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
DOI=10.1021/bi00357a018; PubMed=3636155 [NCBI, ExPASy, EBI, Israel, Japan]
Fujikawa K., Chung D.W., Hendrickson L.E., Davie E.W.;
"Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein.";
Biochemistry 25:2417-2424(1986).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
DOI=10.1021/bi00397a004; PubMed=2827746 [NCBI, ExPASy, EBI, Israel, Japan]
Asakai R., Davie E.W., Chung D.W.;
"Organization of the gene for human factor XI.";
Biochemistry 26:7221-7228(1987).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
DOI=10.1074/jbc.273.22.13787; PubMed=9593722 [NCBI, ExPASy, EBI, Israel, Japan]
Hsu T.-C., Shore S.K., Seshsmma T., Bagasra O., Walsh P.N.;
"Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene.";
J. Biol. Chem. 273:13787-13793(1998).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PHE-339.
SeattleSNPs variation discovery resource;
Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature03466; PubMed=15815621 [NCBI, ExPASy, EBI, Israel, Japan]
Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., Wilson R.K.;
"Generation and annotation of the DNA sequences of human chromosomes 2 and 4.";
Nature 434:724-731(2005).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
PARTIAL PROTEIN SEQUENCE, AND DISULFIDE BONDS.
DOI=10.1021/bi00222a008; PubMed=1998667 [NCBI, ExPASy, EBI, Israel, Japan]
McMullen B.A., Fujikawa K., Davie E.W.;
"Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains.";
Biochemistry 30:2056-2060(1991).
[8]
HEPARIN-BINDING SITE.
DOI=10.1021/bi0027433; PubMed=11412111 [NCBI, ExPASy, EBI, Israel, Japan]
Badellino K.O., Walsh P.N.;
"Localization of a heparin binding site in the catalytic domain of factor XIa.";
Biochemistry 40:7569-7580(2001).
[9]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-126; ASN-450 AND ASN-491, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
[10]
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17 AND THR-22, AND MASS SPECTROMETRY.
DOI=10.2116/analsci.24.161; PubMed=18187866 [NCBI, ExPASy, EBI, Israel, Japan]
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Anal. Sci. 24:161-166(2008).
[11]
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-450 AND ASN-491, AND MASS SPECTROMETRY.
TISSUE=Liver;
DOI=10.1021/pr8008012; PubMed=19159218 [NCBI, ExPASy, EBI, Israel, Japan]
Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
"Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.";
J. Proteome Res. 8:651-661(2009).
[12]
VARIANT F11 DEFICIENCY LEU-301.
DOI=10.1073/pnas.86.20.7667; PubMed=2813350 [NCBI, ExPASy, EBI, Israel, Japan]
Asakai R., Chung D.W., Ratnoff O.D., Davie E.W.;
"Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.";
Proc. Natl. Acad. Sci. U.S.A. 86:7667-7671(1989).
[13]
VARIANT F11 DEFICIENCY LEU-301.
PubMed=1547342 [NCBI, ExPASy, EBI, Israel, Japan]
Meijers J.C., Davie E.W., Chung D.W.;
"Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency.";
Blood 79:1435-1440(1992).
[14]
VARIANTS F11 DEFICIENCY HIS-34; PRO-320; ILE-322 AND LYS-341.
PubMed=7888672 [NCBI, ExPASy, EBI, Israel, Japan]
Pugh R.E., McVey J.H., Tuddenham E.G., Hancock J.F.;
"Six point mutations that cause factor XI deficiency.";
Blood 85:1509-1516(1995).
[15]
VARIANT F11 DEFICIENCY VAL-460.
DOI=10.1111/j.1365-2141.1995.tb05215.x; PubMed=7669672 [NCBI, ExPASy, EBI, Israel, Japan]
Imanaka Y., Lal K., Nishimura T., Bolton-Maggs P.H., Tuddenham E.G., McVey J.H.;
"Identification of two novel mutations in non-Jewish factor XI deficiency.";
Br. J. Haematol. 90:916-920(1995).
[16]
VARIANT F11 DEFICIENCY ASN-404.
DOI=10.1046/j.1365-2141.1997.4343244.x; PubMed=9401068 [NCBI, ExPASy, EBI, Israel, Japan]
Wistinghausen B., Reischer A., Oddoux C., Ostrer H., Nardi M., Karpatkin M.;
"Severe factor XI deficiency in an Arab family associated with a novel mutation in exon 11.";
Br. J. Haematol. 99:575-577(1997).
[17]
VARIANTS F11 DEFICIENCY ARG-244 AND ASN-266.
PubMed=9787168 [NCBI, ExPASy, EBI, Israel, Japan]
Martincic D., Zimmerman S.A., Ware R.E., Sun M.-F., Whitlock J.A., Gailani D.;
"Identification of mutations and polymorphisms in the factor XI genes of an African American family by dideoxyfingerprinting.";
Blood 92:3309-3317(1998).
[18]
ERRATUM.
Martincic D., Zimmerman S.A., Ware R.E., Sun M.-F., Whitlock J.A., Gailani D.;
Blood 93:1786-1786(1999).
[19]
VARIANT F11 DEFICIENCY CYS-246.
DOI=10.1046/j.1365-2141.1999.01150.x; PubMed=10027710 [NCBI, ExPASy, EBI, Israel, Japan]
Alhaq A., Mitchell M., Sethi M., Rahman S., Flynn G., Boulton P., Caeno G., Smith M., Savidge G.;
"Identification of a novel mutation in a non-Jewish factor XI deficient kindred.";
Br. J. Haematol. 104:44-49(1999).
[20]
VARIANTS F11 DEFICIENCY CYS-326; VAL-430 AND ARG-594.
DOI=10.1046/j.1365-2141.1999.01769.x; PubMed=10606881 [NCBI, ExPASy, EBI, Israel, Japan]
Mitchell M., Cutler J., Thompson S., Moore G., Jenkins Ap Rees E., Smith M., Savidge G., Alhaq A.;
"Heterozygous factor XI deficiency associated with three novel mutations.";
Br. J. Haematol. 107:763-765(1999).
[21]
VARIANTS LEU-66; ARG-244; PHE-308 AND PHE-339.
DOI=10.1038/10290; PubMed=10391209 [NCBI, ExPASy, EBI, Israel, Japan]
Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S.;
"Characterization of single-nucleotide polymorphisms in coding regions of human genes.";
Nat. Genet. 22:231-238(1999).
[22]
ERRATUM.
Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S.;
Nat. Genet. 23:373-373(1999).
[23]
VARIANTS F11 DEFICIENCY ARG-56; TYR-255 AND HIS-511, VARIANT PHE-339, AND CHARACTERIZATION OF VARIANTS F11 DEFICIENCY ARG-56; TYR-255 AND HIS-511.
DOI=10.1182/blood.V99.7.2448; PubMed=11895778 [NCBI, ExPASy, EBI, Israel, Japan]
Zivelin A., Bauduer F., Ducout L., Peretz H., Rosenberg N., Yatuv R., Seligsohn U.;
"Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene.";
Blood 99:2448-2454(2002).
[24]
VARIANTS F11 DEFICIENCY VAL-418 AND SER-587, AND CHARACTERIZATION OF VARIANTS F11 DEFICIENCY VAL-418 AND SER-587.
DOI=10.1182/blood-2003-10-3530; PubMed=15026311 [NCBI, ExPASy, EBI, Israel, Japan]
Kravtsov D.V., Wu W., Meijers J.C.M., Sun M.-F., Blinder M.A., Dang T.P., Wang H., Gailani D.;
"Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.";
Blood 104:128-134(2004).
[25]
VARIANT F11 DEFICIENCY ILE-270, AND CHARACTERIZATION OF VARIANT F11 DEFICIENCY ILE-270.
DOI=10.1111/j.1365-2141.2004.04979.x; PubMed=15180874 [NCBI, ExPASy, EBI, Israel, Japan]
Dai L., Mitchell M., Carson P., Creagh D., Cutler J., Savidge G., Alhaq A.;
"Severe factor XI deficiency caused by compound heterozygosity.";
Br. J. Haematol. 125:817-818(2004).
[26]
VARIANTS F11 DEFICIENCY PHE-46; ARG-101; CYS-151; GLU-263; VAL-430; LEU-538; LYS-565 AND SER-618.
DOI=10.1111/j.1365-2141.2005.05536.x; PubMed=15953011 [NCBI, ExPASy, EBI, Israel, Japan]
Hill M., McLeod F., Franks H., Gordon B., Dolan G.;
"Genetic analysis in FXI deficiency: six novel mutations and the use of a polymerase chain reaction-based test to define a whole gene deletion.";
Br. J. Haematol. 129:825-829(2005).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
M13142; AAA52487.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M20218; AAA51985.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18296; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M21184; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18298; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18299; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18300; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18301; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18302; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18303; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M18304; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M19417; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
M20217; AAA51985.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AF045649; AAC24506.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AY191837; AAN85554.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC110771; AAY40901.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC119014; AAI19015.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC122863; AAI22864.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
IPI IPI00008556; -.
IPI00216588; -.
PIR A27431; KFHU1.
RefSeq NP_000119.1; -.
UniGene Hs.1430
3D structure databases
PDB
1XX9; X-ray; 2.20 A; A/B=388-625.[ExPASy / RCSB / EBI]
1XXD; X-ray; 2.91 A; A/B=388-625.[ExPASy / RCSB / EBI]
1XXF; X-ray; 2.60 A; A/B=388-625.[ExPASy / RCSB / EBI]
1ZHM; X-ray; 1.96 A; A=388-624.[ExPASy / RCSB / EBI]
1ZHP; X-ray; 2.70 A; A=388-625.[ExPASy / RCSB / EBI]
1ZHR; X-ray; 1.73 A; A=388-625.[ExPASy / RCSB / EBI]
1ZJD; X-ray; 2.60 A; A=388-624.[ExPASy / RCSB / EBI]
1ZLR; X-ray; 2.50 A; A=388-624.[ExPASy / RCSB / EBI]
1ZMJ; X-ray; 2.00 A; A=388-624.[ExPASy / RCSB / EBI]
1ZML; X-ray; 2.25 A; A=388-625.[ExPASy / RCSB / EBI]
1ZMN; X-ray; 2.05 A; A=388-625.[ExPASy / RCSB / EBI]
1ZOM; X-ray; 2.25 A; A=388-624.[ExPASy / RCSB / EBI]
1ZPB; X-ray; 2.10 A; A=388-624.[ExPASy / RCSB / EBI]
1ZPC; X-ray; 2.60 A; A=388-624.[ExPASy / RCSB / EBI]
1ZPZ; X-ray; 2.50 A; A=388-625.[ExPASy / RCSB / EBI]
1ZRK; X-ray; 2.30 A; A=388-625.[ExPASy / RCSB / EBI]
1ZSJ; X-ray; 1.90 A; A=388-625.[ExPASy / RCSB / EBI]
1ZSK; X-ray; 1.90 A; A=388-625.[ExPASy / RCSB / EBI]
1ZSL; X-ray; 2.05 A; A=388-625.[ExPASy / RCSB / EBI]
1ZTJ; X-ray; 2.05 A; A=388-625.[ExPASy / RCSB / EBI]
1ZTK; X-ray; 2.50 A; A=388-625.[ExPASy / RCSB / EBI]
1ZTL; X-ray; 2.60 A; A=388-625.[ExPASy / RCSB / EBI]
2F83; X-ray; 2.87 A; A=1-625.[ExPASy / RCSB / EBI]
2FDA; X-ray; 2.00 A; A=388-625.[ExPASy / RCSB / EBI]
2J8J; NMR; -; A/B=290-379.[ExPASy / RCSB / EBI]
2J8L; NMR; -; A/B=290-379.[ExPASy / RCSB / EBI]
3BG8; X-ray; 1.60 A; A=388-625.[ExPASy / RCSB / EBI]
Detailed list of linked structures.
PDBsum 1XX9; -.
1XXD; -.
1XXF; -.
1ZHM; -.
1ZHP; -.
1ZHR; -.
1ZJD; -.
1ZLR; -.
1ZMJ; -.
1ZML; -.
1ZMN; -.
1ZOM; -.
1ZPB; -.
1ZPC; -.
1ZPZ; -.
1ZRK; -.
1ZSJ; -.
1ZSK; -.
1ZSL; -.
1ZTJ; -.
1ZTK; -.
1ZTL; -.
2F83; -.
2FDA; -.
2J8J; -.
2J8L; -.
3BG8; -.
ModBase P03951.
Protein-protein interaction databases
DIP DIP:29085N; -.
Protein family/group databases
MEROPS S01.213; -.
PTM databases
PhosphoSite P03951; -.
Enzyme and pathway databases
BRENDA 3.4.21.27; 247.
Reactome REACT_604; Hemostasis.
Organism-specific databases
GeneCards GC04P187424; -.
H-InvDB HIX0031358; -.
HGNC HGNC:3529; F11.
GenAtlas F11.
MIM 264900; gene. [NCBI / EBI]
612416; phenotype. [NCBI / EBI]
Orphanet 329; Congenital factor XI deficiency.
PharmGKB PA24968; -.
Gene expression databases
ArrayExpress P03951; -.
Bgee P03951; -.
CleanEx HS_F11; -.
GermOnline ENSG00000088926; Homo sapiens.
Ontologies
GO
GO:0005615; Cellular component: extracellular space (inferred from direct assay from UniProtKB).
GO:0016020; Cellular component: membrane (non-traceable author statement from UniProtKB).
GO:0008201; Molecular function: heparin binding (inferred from electronic annotation from UniProtKB-KW).
GO:0004252; Molecular function: serine-type endopeptidase activity (non-traceable author statement from UniProtKB).
GO:0007596; Biological process: blood coagulation (non-traceable author statement from UniProtKB).
GO:0031639; Biological process: plasminogen activation (inferred from direct assay from UniProtKB).
GO:0051919; Biological process: positive regulation of fibrinolysis (inferred from direct assay from UniProtKB).
GO:0006508; Biological process: proteolysis (inferred from electronic annotation from InterPro).
QuickGo view.
Family and domain databases
InterPro IPR000177; Apple.
IPR003014; PAN-1_domain.
IPR003609; Pan_app.
IPR018114; Peptidase_S1/S6_AS.
IPR001254; Peptidase_S1_S6.
IPR001314; Peptidase_S1A.
Graphical view of domain structure.
Pfam PF00024; PAN_1; 4.
PF00089; Trypsin; 1.
Pfam graphical view of domain structure.
PRINTS PR00005; APPLEDOMAIN.
PR00722; CHYMOTRYPSIN.
SMART SM00223; APPLE; 4.
SM00020; Tryp_SPc; 1.
SMART graphical view of domain structure.
PROSITE PS00495; APPLE; 4.
PS50948; PAN; 4.
PS50240; TRYPSIN_DOM; 1.
PS00134; TRYPSIN_HIS; 1.
PS00135; TRYPSIN_SER; 1.
PROSITE graphical view of domain structure (profiles).
Proteomic databases
PeptideAtlas P03951; -.
PRIDE P03951; -.
Genome annotation databases
Ensembl ENSG00000088926; Homo sapiens. [Contig view]
GeneID 2160; -.
KEGG hsa:2160; -.
NMPDR fig|9606.3.peg.24953; -.
Phylogenomic databases
HOGENOM P03951; -.
HOVERGEN P03951; -.
OMA P03951; QRPICLP.
Other
BindingDB P03951; -.
DrugBank DB00100; Coagulation Factor IX.
NextBio 8727; -.
PMAP-CutDB P03951; -.
SOURCE F11; Homo sapiens.
ProtoNet P03951.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
3D-structure; Alternative splicing; Blood coagulation; Direct protein sequencing; Disease mutation; Disulfide bond; Glycoprotein; Heparin-binding; Hydrolase; Phosphoprotein; Polymorphism; Protease; Repeat; Secreted; Serine protease; Signal.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1    18  18      
CHAIN   19   387  369     Coagulation factor XIa heavy chain. PRO_0000027825
CHAIN   388   625  238     Coagulation factor XIa light chain. PRO_0000027826
DOMAIN   20   103  84     Apple 1. 
DOMAIN   110   193  84     Apple 2. 
DOMAIN   200   283  84     Apple 3. 
DOMAIN   291   374  84     Apple 4. 
DOMAIN   388   623  236     Peptidase S1. 
REGION   547   550  4     Heparin-binding. 
ACT_SITE   431   431        Charge relay system. 
ACT_SITE   480   480        Charge relay system. 
ACT_SITE   575   575        Charge relay system. 
MOD_RES   17    17        Phosphoserine. 
MOD_RES   22    22        Phosphothreonine. 
CARBOHYD   90    90        N-linked (GlcNAc...). 
CARBOHYD   126   126        N-linked (GlcNAc...). 
CARBOHYD   353   353        N-linked (GlcNAc...). 
CARBOHYD   450   450        N-linked (GlcNAc...). 
CARBOHYD   491   491        N-linked (GlcNAc...). 
DISULFID   20   103        Potential. 
DISULFID   29    29        Interchain. 
DISULFID   46    76         
DISULFID   50    56         
DISULFID   110   193         
DISULFID   136   165         
DISULFID   140   146         
DISULFID   200   283         
DISULFID   226   255         
DISULFID   230   236         
DISULFID   291   374         
DISULFID   317   346         
DISULFID   321   327         
DISULFID   339   339        Interchain (Potential). 
DISULFID   380   500        Interchain (between heavy and light chains). 
DISULFID   416   432         
DISULFID   514   581        Potential. 
DISULFID   545   560         
DISULFID   571   599        Potential. 
VAR_SEQ   109   162        Missing (in isoform 2). VSP_005388
VARIANT   34    34  1     D -> H (in F11 deficiency). VAR_012085 
VARIANT   46    46  1     C -> F (in F11 deficiency). VAR_054894 
VARIANT   56    56  1     C -> R (in F11 deficiency; autosomal dominant; secretion of the mutant protein is impaired). VAR_054895 
VARIANT   66    66  1     P -> L (in dbSNP:rs5968 [NCBI]). VAR_011774 
VARIANT   101   101  1     K -> R (in F11 deficiency). VAR_054896 
VARIANT   151   151  1     Y -> C (in F11 deficiency). VAR_054897 
VARIANT   244   244  1     Q -> R (in F11 deficiency; dbSNP:rs5969 [NCBI]). VAR_011775 
VARIANT   246   246  1     W -> C (in F11 deficiency). VAR_012086 
VARIANT   255   255  1     C -> Y (in F11 deficiency; secretion of the mutant protein is impaired). VAR_054898 
VARIANT   263   263  1     G -> E (in F11 deficiency). VAR_054899 
VARIANT   266   266  1     S -> N (in F11 deficiency). VAR_012087 
VARIANT   270   270  1     K -> I (in F11 deficiency; although the mutant protein is synthesized the secretion is reduced). VAR_054900 
VARIANT   301   301  1     F -> L (in F11 deficiency; frequent mutation in Ashkenazi patients). VAR_006622 
VARIANT   308   308  1     I -> F (in dbSNP:rs5972 [NCBI]). VAR_011776 
VARIANT   320   320  1     L -> P (in F11 deficiency). VAR_012088 
VARIANT   322   322  1     T -> I (in F11 deficiency). VAR_012089 
VARIANT   326   326  1     R -> C (in F11 deficiency). VAR_012090 
VARIANT   339   339  1     C -> F (in dbSNP:rs5967 [NCBI]). VAR_011777 
VARIANT   341   341  1     E -> K (in F11 deficiency). VAR_012091 
VARIANT   399   399  1     W -> R (in dbSNP:rs1800439 [NCBI]). VAR_011778 [3D]
VARIANT   404   404  1     T -> N (in F11 deficiency). VAR_012092 [3D]
VARIANT   418   418  1     G -> V (in F11 deficiency; autosomal dominant; mutant is not secreted by transfected fibroblasts; dominant-negative effect). VAR_054901 [3D]
VARIANT   430   430  1     A -> V (in F11 deficiency). VAR_012093 [3D]
VARIANT   460   460  1     F -> V (in F11 deficiency). VAR_012094 [3D]
VARIANT   493   493  1     T -> I (in F11 deficiency). VAR_012095 [3D]
VARIANT   511   511  1     Y -> H (in F11 deficiency; transfected cells contain reduced amount of mutant protein and display decreased secretion). VAR_054902 [3D]
VARIANT   538   538  1     P -> L (in F11 deficiency). VAR_054903 [3D]
VARIANT   565   565  1     E -> K (in F11 deficiency). VAR_054904 [3D]
VARIANT   587   587  1     W -> S (in F11 deficiency; autosomal dominant; mutant is not secreted by transfected fibroblasts; dominant-negative effect). VAR_054905 [3D]
VARIANT   594   594  1     S -> R (in F11 deficiency). VAR_012096 [3D]
VARIANT   618   618  1     I -> S (in F11 deficiency). VAR_054906 [3D]
CONFLICT   226   226        C -> S (in Ref. 2; AAA51985). 
STRAND   25    30  6      
STRAND   34    39  6      
HELIX   43    52  10      
STRAND   53    55  3      
STRAND   58    62  5      
TURN   71    74  4      
STRAND   75    79  5      
HELIX   82    84  3      
STRAND   88    98  11      
STRAND   115   121  7      
STRAND   123   129  7      
HELIX   133   141  9      
STRAND   143   145  3      
STRAND   147   152  6      
STRAND   159   161  3      
STRAND   164   169  6      
STRAND   171   174  4      
STRAND   176   188  13      
TURN   191   194  4      
STRAND   205   209  5      
STRAND   212   219  8      
HELIX   223   231  9      
STRAND   237   242  6      
HELIX   249   251  3      
STRAND   254   259  6      
STRAND   261   264  4      
STRAND   269   278  10      
HELIX   281   283  3      
STRAND   304   313  10      
HELIX   316   323  8      
STRAND   329   333  5      
TURN   337   339  3      
STRAND   344   350  7      
STRAND   352   354  3      
STRAND   366   369  4      
HELIX   374   376  3      
STRAND   402   422  21      
STRAND   425   428  4      
HELIX   430   433  4      
HELIX   439   441  3      
STRAND   442   447  6      
HELIX   451   453  3      
STRAND   461   468  8      
TURN   475   477  3      
STRAND   482   488  7      
STRAND   514   519  6      
STRAND   533   536  4      
HELIX   542   548  7      
TURN   549   551  3      
STRAND   558   561  4      
STRAND   578   583  6      
STRAND   586   600  15      
STRAND   606   609  4      
HELIX   611   614  4      
HELIX   615   622  8      
Sequence information
Length: 625 AA [This is the length of the unprocessed precursor] Molecular weight: 70109 Da [This is the MW of the unprocessed precursor] CRC64: 147AFA94B7709E8F [This is a checksum on the sequence]
        10         20         30         40         50         60 
MIFLYQVVHF ILFTSVSGEC VTQLLKDTCF EGGDITTVFT PSAKYCQVVC TYHPRCLLFT 

        70         80         90        100        110        120 
FTAESPSEDP TRWFTCVLKD SVTETLPRVN RTAAISGYSF KQCSHQISAC NKDIYVDLDM 

       130        140        150        160        170        180 
KGINYNSSVA KSAQECQERC TDDVHCHFFT YATRQFPSLE HRNICLLKHT QTGTPTRITK 

       190        200        210        220        230        240 
LDKVVSGFSL KSCALSNLAC IRDIFPNTVF ADSNIDSVMA PDAFVCGRIC THHPGCLFFT 

       250        260        270        280        290        300 
FFSQEWPKES QRNLCLLKTS ESGLPSTRIK KSKALSGFSL QSCRHSIPVF CHSSFYHDTD 

       310        320        330        340        350        360 
FLGEELDIVA AKSHEACQKL CTNAVRCQFF TYTPAQASCN EGKGKCYLKL SSNGSPTKIL 

       370        380        390        400        410        420 
HGRGGISGYT LRLCKMDNEC TTKIKPRIVG GTASVRGEWP WQVTLHTTSP TQRHLCGGSI 

       430        440        450        460        470        480 
IGNQWILTAA HCFYGVESPK ILRVYSGILN QSEIKEDTSF FGVQEIIIHD QYKMAESGYD 

       490        500        510        520        530        540 
IALLKLETTV NYTDSQRPIC LPSKGDRNVI YTDCWVTGWG YRKLRDKIQN TLQKAKIPLV 

       550        560        570        580        590        600 
TNEECQKRYR GHKITHKMIC AGYREGGKDA CKGDSGGPLS CKHNEVWHLV GITSWGEGCA 

       610        620 
QRERPGVYTN VVEYVDWILE KTQAV 

P03951 in FASTA format

View entry in raw text format (no links)
Report form for errors/updates in this UniProtKB/Swiss-Prot entry

BLAST logo BLAST submission on ExPASy/SIB
or at NCBI (USA)
Tools Sequence analysis tools: ProtParam, ProtScale, Compute pI/Mw, PeptideMass, PeptideCutter, Dotlet (Java)
PROSITE logo ScanProsite, MotifScan SWISS-MODEL Submit a homology modeling request to SWISS-MODEL
NPSA logo NPSA Sequence analysis tools

ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
 Hosted by ch flag SIB Switzerland Mirror sites: Australia  Brazil  Canada  China  Korea
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!